According to a study by the American Heart Association (AHA), around 5 million Americans are diagnosed with moderate or severe heart valve disease. The disease might affect single valve or combination among the four valves, the most commonly affected are aortic and mitral valves. If the condition is not diagnosed at right time or is left untreated, it further deteriorates the condition of heart leading to failure. The growth in prevalence of heart valve disease has been recently observed due to associated risk factors such as sedentary lifestyle, stress, irregular sleeping habits and rise in geriatric population. Increase in incidence of heart valve disease and advancement of technology are the key factors for growth of heart device market. Technological advancement in transcatheter aortic valve replacement or transcatheter mitral valve replacement is fuelling the demand of heart valve devices.
The report titled “Heart Valve Devices Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall heart valve devices market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of procedure and different geographies. The procedure types studied for analyzing the overall global heart valve devices market are majorly segmented into heart valve repair devices and heart valve replacement. Heart valve repair is further segmented into surgical heart valve repair devices, percutaneous balloon valvuloplasty devices and transcatheter heart valve repair devices. Heart valve replacement is segmented by type into mechanical valves, tissue/bioprosthetic valves and transcatheter heart valves/ percutaneous heart valves. It is further segmented into position by mitral valve replacement devices, aortic valve replacement devices and other position heart valve replacement devices.
Geographically, the global heart valve devices market is studied for the following regional markets:
- North America
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of LATAM
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year. Further cross-sectional presented in terms of procedure type and constituent country level markets is also included in this section.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global heart valve devices market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global heart valve devices market. This report concludes with company profiles section that highlights major information about the key players engaged in the global heart valve devices market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.
Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the heart valve devices market. The key players profiled in this report are Abbott Laboratories, Boston Scientific Corporation, Cryolife, Inc., Edwards Lifesciences LLC, On-X Life Technologies, Inc., LivaNova, Plc., Medtronic, Plc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., Neovasc, Inc., Sorin Group, St.Jude Medical, Inc., TTK Healthcare Ltd and others.
